We use cookies on our site to analyze traffic, enhance your experience, and provide you with tailored content.

For more information visit our privacy policy.

Cadus Pharmaceutical Corp Sample Contracts

Standard Contracts

WITNESSETH:
Employment Agreement • November 13th, 1998 • Cadus Pharmaceutical Corp • Services-commercial physical & biological research • New York
EXHIBIT 10.28 ASSET PURCHASE AGREEMENT
Asset Purchase Agreement • August 16th, 1999 • Cadus Pharmaceutical Corp • Services-commercial physical & biological research • New York
Exhibit 4.1 STOCK PURCHASE AGREEMENT
Stock Purchase Agreement • March 11th, 1997 • Cadus Pharmaceutical Corp • Services-commercial physical & biological research • New York
RESEARCH COLLABORATION AND LICENSE AGREEMENT BETWEEN CADUS PHARMACEUTICAL CORPORATION AND SMITHKLINE BEECHAM DATED AS OF FEBRUARY 25th, 1997
Research Collaboration and License Agreement • May 13th, 1997 • Cadus Pharmaceutical Corp • Services-commercial physical & biological research • New York
WITNESSETH:
Employment Agreement • November 13th, 1998 • Cadus Pharmaceutical Corp • Services-commercial physical & biological research • New York
W I T N E S S E T H: - - - - - - - - - -
Yeast Technology License Agreement • May 15th, 2000 • Cadus Pharmaceutical Corp • Services-commercial physical & biological research • New York
AGREEMENT AND PLAN OF MERGER among CADUS CORPORATION, STARFIRE HOLDING CORPORATION and CADUS MERGER SUB LLC DATED AS OF JANUARY 20, 2018
Merger Agreement • January 22nd, 2018 • Cadus Corp • Real estate • Delaware

THIS AGREEMENT AND PLAN OF MERGER (this “Agreement”), is dated as of January 20, 2018, among Cadus Corporation, a Delaware corporation (the “Company”), Starfire Holding Corporation, a Delaware corporation (“Parent”), and Cadus Merger Sub LLC, a Delaware limited liability company (“Merger Sub”).

Employment Agreement
Employment Agreement • March 10th, 2014 • Cadus Corp • Biological products, (no disgnostic substances) • New York

This Employment Agreement (this “Agreement”) is dated as of March 5, 2014, and is made by and between Cadus Corporation, a Delaware corporation (the “Company”), and Hunter C. Gary (“Executive”).